Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2007622 Target Snapshot

Mitochondrial peptide methionine sulfoxide reductase · SINGLE PROTEIN · Bos taurus

330Compounds
2Assays
0Approved Drugs
337.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P54149. Use UniProt P54149 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P54149 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mitochondrial peptide methionine sulfoxide reductase as ChEMBL target CHEMBL2007622, mapped to UniProt P54149. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mitochondrial peptide methionine sulfoxide reductase
SINGLE PROTEIN · Bos taurus
As of 2026-09-13
ChEMBL target ID
CHEMBL2007622
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P54149
Mitochondrial peptide methionine sulfoxide reductase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mitochondrial peptide methionine sulfoxide reductase is the right protein anchor across sources, using UniProt P54149 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMitochondrial peptide methionine sulfoxide reductase
UniProt AccessionP54149
Component TypeProtein
Sequence Length233 aa

Mitochondrial peptide methionine sulfoxide reductase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mitochondrial peptide methionine sulfoxide reductase, mapped to UniProt P54149. Sequence length is 233 aa.

Mapped IDP54149
Review nameMitochondrial peptide methionine sulfoxide reductase
OrganismBos taurus
Assay Mix

Activity Type Distribution

IC50226.0
EC50111.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1497838 5.67 EC50 2127.0 Preclinical
CHEMBL1485159 5.45 EC50 3534.0 Preclinical
CHEMBL235504 5.44 EC50 3637.0 Preclinical
CHEMBL417727 5.04 EC50 9088.0 Preclinical
CHEMBL1870250 4.99 EC50 10330.0 Preclinical
CHEMBL1887807 4.89 EC50 12900.0 Preclinical
CHEMBL1728280 4.85 EC50 14085.0 Preclinical
CHEMBL1489745 4.8 EC50 15803.0 Preclinical
CHEMBL2373711 4.8 EC50 15779.0 Preclinical
CHEMBL1613638 4.76 EC50 17416.0 Preclinical
Distribution

pChEMBL Value Distribution

3
5.0
1
5.5
0
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

2
Total Assays
42
Tested Compounds
1
Assay Types
Functional — 2 assays, 42 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 42 4.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine